Research
Clinical Trials
Clinical trials strive to find solutions to some of life’s most complex conditions, diseases, and disorders. They are modern medicine’s answer to the questions “why?” and “how?”
Through clinical trials, we find out whether a new treatment works and is safe. For many, they provide hope and promise for an improved quality of life. They are carefully designed research studies that answer specific questions about the effectiveness of preventive techniques, medications, therapies and treatments and surgical techniques.
About the Center for Clinical Trials
The Department of Urology’s Center for Clinical Trials is a clinical research center that helps facilitate innovative new products and medications for the research community and patients by conducting Phase Ⅰ - Ⅳ clinical trials. Phase Ⅰ is the safety and tolerability of treatment in a small number of individuals. Phase Ⅱ is the efficacy of treatment that is proven to be safe for humans. Phase Ⅲ is the comparison of treatment to current FDA approved treatments in a larger group number of participants. Phase Ⅳ is studying the long term data of the treatment after being on the market.
Participation in a clinical trial does not substitute for regular medical care. Discuss participation in clinical trials with your physician. For more information about current clinical trials, or the clinical trial process at the University of Minnesota, please contact either:
Tracy Daye-Groves at [email protected] or 612-625-3319
Maressa Twedt at [email protected] or 612-626-6661
Clinical Trials by Urology Specialty Area
Interested in participating? Click an area of your interest to view the clinical trials being conducted.
Bladder Cancer Treatments
EG-70 Study
Study Title: A Phase 1/2 of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMBIC
Principal Investigator: Dr. Joseph Zabell
Currently Recruiting
FIDIA Study
Study Title: A phase III, single-arm study to evaluate the efficacy and safety of ONCOFID-P-B (paclitaxel-hyaluronic acid conjugate) administered intravesically to patients with BCG-unresponsive Carcinoma in Situ of the bladder with or without Ta-T1 papillary disease.
Principal Investigator: Dr. Hamed Ahmadi
Soon to be Recruiting
Other Bladder Studies
Prostate Cancer
Vapor 2 Study
Study Title: Prospective, Multicenter, Single-Arm study of VanquishTM Water Vapor Ablation of PrOstate CanceR.
Principal Investigator: Dr. Christopher Warlick
Currently Recruiting
Targeted-Ex Study
Study Title: EX-VIVO TARGETED TREATMENT OF CANCEROUS EXPIRPATED PROSTATE TISSUE.
Principal Investigator: Dr. Christopher Warlick
Currently Recruiting
Urine Protein biomarkers in prostate cancer
Study Title: Development of Protein Biomarkers from Urine of Prostate Cancer Patients.
Principal Investigator: Dr. Christopher Warlick
Currently Recruiting
Benign Prostatic Hyperplasia
Butterfly Pivotal Study
Study Title: A prospective, randomized, controlled, blinded study to assess the Safety and Efficacy of the Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients.
Principal Investigator: Dr. Michael Borofsky and Dr. Deepak Agarwal
Currently Recruiting
Overactive Bladder
Urovant Vibegron Study
Study Title: Composur, A Patient-centric, Phase IV, Open-label, Prospective, Real World US Study to Evaluate Vibegron on Patient Treatment Satisfaction, Quality of Life, and Healthcare Resource Utilization in Patients with Overactive Bladder
Principal Investigator: Dr. Nissrine Nakib
Closed to Recruiting
Urinary Incontinence
Kidney Stones
Male Infertility
Sacral Nerve Neuromodulation Therapy
Urology Department Collaboration Studies
More to be coming soon! Please check back.
Looking to participate in a study?
Research Ethics at the University of Minnesota
We are committed to protecting research participants, upholding ethical standards, and improving our practice at every step of our work.